Janis K. Burkhardt

Affiliations: 
Cell and Molecular Biology University of Pennsylvania, Philadelphia, PA, United States 
Area:
Cell Biology, Immunology, Molecular Biology
Google:
"Janis Burkhardt"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Allman A, Gaudette BT, Kelly S, et al. (2024) Splenic fibroblasts control marginal zone B cell movement and function via two distinct Notch2-dependent regulatory programs. Immunity
Gómez Atria D, Gaudette BT, Londregan J, et al. (2022) Stromal Notch ligands foster lymphopenia-driven functional plasticity and homeostatic proliferation of naïve B cells. The Journal of Clinical Investigation
Avery L, Robertson TF, Wu CF, et al. (2022) A Murine Model of X-Linked Moesin-Associated Immunodeficiency (X-MAID) Reveals Defects in T Cell Homeostasis and Migration. Frontiers in Immunology. 12: 726406
Singh N, Frey NV, Engels B, et al. (2021) Antigen-independent activation enhances the efficacy of 4-1BB-costimulated CD22 CAR T cells. Nature Medicine
Robertson TF, Chengappa P, Gomez Atria D, et al. (2021) Lymphocyte egress signal sphingosine-1-phosphate promotes ERM-guided, bleb-based migration. The Journal of Cell Biology. 220
Roy NH, Kim SHJ, Buffone A, et al. (2020) LFA-1 signals to promote actin polymerization and upstream migration in T cells. Journal of Cell Science. 133
Forsyth KS, Roy NH, Peauroi E, et al. (2020) Ectromelia-encoded virulence factor C15 specifically inhibits antigen presentation to CD4+ T cells post peptide loading. Plos Pathogens. 16: e1008685
Blumenthal D, Chandra V, Avery L, et al. (2020) Mouse T cell priming is enhanced by maturation-dependent stiffening of the dendritic cell cortex. Elife. 9
Cook SA, Comrie WA, Poli MC, et al. (2020) HEM1 deficiency disrupts mTORC2 and F-actin control in inherited immunodysregulatory disease. Science (New York, N.Y.). 369: 202-207
Roy NH, Mammadli M, Burkhardt JK, et al. (2020) CrkL is required for donor T cell migration to GvHD target organs. Oncotarget. 11: 1505-1514
See more...